Ethos Veterinary Health
  • NVA Group
  • About Us
    • About Us
    • Executive Team
    • Our Hospitals
  • Advancing Medicine
    • Meet Our Medical Leadership Team
    • Medical Excellence
    • Medical Operations
    • New Product Committee
    • Specialty Advisory Board
    • Ethos Science
    • Blood Bank Programs
    • Clinical Studies
      • Open & Enrolling Studies
      • FAQs: Clinical Studies at Ethos
    • Ethos Discovery
  • Ethos Updates
  • Careers + Development
    • Ethos is Hiring
      • Career Opportunities
      • Employee Benefits
      • Meet Our Talent Teams
      • Referral Program
    • Training Programs
      • Veterinary Training Programs
      • Veterinary Nursing Programs
    • Careers Unleashed
    • VetBloom
    • Veterinary Conferences
Ethos Veterinary Health
  • About Us
    • About Us
    • Executive Team
    • Our Hospitals
  • Advancing Medicine
    • Meet Our Medical Leadership Team
    • Medical Excellence
    • Medical Operations
    • New Product Committee
    • Specialty Advisory Board
    • Ethos Science
    • Blood Bank Programs
    • Clinical Studies
      • Open & Enrolling Studies
      • FAQs: Clinical Studies at Ethos
    • Ethos Discovery
  • Ethos Updates
  • Careers + Development
    • Ethos is Hiring
      • Career Opportunities
      • Employee Benefits
      • Meet Our Talent Teams
      • Referral Program
    • Training Programs
      • Veterinary Training Programs
      • Veterinary Nursing Programs
    • Careers Unleashed
    • VetBloom
    • Veterinary Conferences
  • NVA Group

News

Ethos Discovery named semi-finalist for AKC Canine Health Foundation’s Canine Health Discovery of the Year Award

November 4, 2025

Ethos Discovery has been recognized as one of eight semi-finalists for the AKC Canine Health Foundation’s inaugural Canine Health Discovery of the Year Award, celebrating groundbreaking research shaping the future of canine health.

Ethos Discovery’s landmark PUSH Study, led by Chand Khanna, DVM, PhD, DACVIM (Oncology), DACVP, Jake Cawley, DVM, MS, DACVIM (Oncology), and Sam Stewart, DVM, DACVECC, followed nearly 500 dogs with splenic tumors and uncovered a surprising truth: many of these tumors are benign, not malignant as once believed. This breakthrough is transforming how veterinarians approach diagnosis and treatment, helping spare countless dogs and their families from unnecessary fear, procedures, and loss.

The recognition places Ethos Discovery alongside top research institutions such as Cornell, Tufts, and the University of Illinois, highlighting its leadership in advancing science that benefits animals and humans.

This recognition underscores Ethos Discovery’s unwavering commitment to redefining what’s possible in veterinary medicine through curiosity, collaboration, and compassion.

To learn more about The PUSH Study and how you can get involved, click here.

Share

Recent News

  • From Clinical Study to Critical Care: How Research Funding Saved Running Bear December 4, 2025
  • Leslie Storms Appointed Ethos Veterinary Health President December 1, 2025
  • Join our SAVES leadership team in Lebanon, NH! November 21, 2025
Ethos Veterinary Health
  • NVA Group
© 2025 Ethos Veterinary Health Privacy Policy
Website Design by Jackrabbit